Correction: Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance

Abstract

(Cancer Cell (2022) 40(1) (88–102.e7), (S1535610821006127), (10.1016/j.ccell.2021.11.012)) (Cancer Cell 40, 88–102; January 10, 2022) We, the authors of the paper, described features associated with the response to immunotherapy using multi-omics data from patients with melanoma. After publication, we discovered an error in the script used to prepare Table S1, which led to incorrect annotation in the “Status” column. All patients were listed as “Alive” instead of the appropriate “Alive” or “Dead” status. A corrected Table S1 that accurately reflects the appropriate status for each patient is presented here. This error is confined to Table S1, and the correct annotations were used in all analyses within the paper. Therefore, this change does not affect the interpretation of the results or the conclusions of the study. We apologize for any confusion this error may have caused.